Search

Robert B Beatty

Examiner (ID: 3913, Phone: (571)272-2130 , Office: P/2852 )

Most Active Art Unit
2852
Art Unit(s)
2852, 2105
Total Applications
2973
Issued Applications
2641
Pending Applications
80
Abandoned Applications
252

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14310329 [patent_doc_number] => 20190144868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-16 [patent_title] => Products and Methods for Treatment of Familial Amyotrophic Lateral Sclerosis [patent_app_type] => utility [patent_app_number] => 16/041381 [patent_app_country] => US [patent_app_date] => 2018-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14641 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041381 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/041381
Products and methods for treatment of familial amyotrophic lateral sclerosis Jul 19, 2018 Issued
Array ( [id] => 13827177 [patent_doc_number] => 20190017073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL [patent_app_type] => utility [patent_app_number] => 16/025503 [patent_app_country] => US [patent_app_date] => 2018-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025503 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/025503
COMPOSITIONS AND METHODS FOR DELIVERING NUCLEIC ACID TO A CELL Jul 1, 2018 Abandoned
Array ( [id] => 14098949 [patent_doc_number] => 20190091150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 16/025557 [patent_app_country] => US [patent_app_date] => 2018-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27335 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025557 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/025557
POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME Jul 1, 2018 Abandoned
Array ( [id] => 16894300 [patent_doc_number] => 11035847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-15 [patent_title] => Deterministic stepping of polymers through a nanopore [patent_app_type] => utility [patent_app_number] => 16/022594 [patent_app_country] => US [patent_app_date] => 2018-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 11862 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 249 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16022594 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/022594
Deterministic stepping of polymers through a nanopore Jun 27, 2018 Issued
Array ( [id] => 15239733 [patent_doc_number] => 20190374652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-12 [patent_title] => METHODS AND COMPOSITIONS FOR INCREASING SIALIC ACID PRODUCTION AND TREATING SIALIC RELATED DISEASE CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/006767 [patent_app_country] => US [patent_app_date] => 2018-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8901 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16006767 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/006767
METHODS AND COMPOSITIONS FOR INCREASING SIALIC ACID PRODUCTION AND TREATING SIALIC RELATED DISEASE CONDITIONS Jun 11, 2018 Abandoned
Array ( [id] => 16013607 [patent_doc_number] => 20200181646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => SELF-REGULATING AAV VECTORS FOR SAFE EXPRESSION OF MECP2 IN RETT SYNDROME [patent_app_type] => utility [patent_app_number] => 16/619733 [patent_app_country] => US [patent_app_date] => 2018-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14507 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619733 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/619733
Self-regulating AAV vectors for safe expression of MeCP2 in rett syndrome Jun 5, 2018 Issued
Array ( [id] => 13586655 [patent_doc_number] => 20180344876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => Vectors Conditionally Expressing Protein [patent_app_type] => utility [patent_app_number] => 15/993773 [patent_app_country] => US [patent_app_date] => 2018-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50554 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15993773 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/993773
Vectors Conditionally Expressing Protein May 30, 2018 Abandoned
Array ( [id] => 17306258 [patent_doc_number] => 11207340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => Tumor suppressor TET1 and uses thereof [patent_app_type] => utility [patent_app_number] => 15/988619 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 33 [patent_no_of_words] => 17142 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15988619 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/988619
Tumor suppressor TET1 and uses thereof May 23, 2018 Issued
Array ( [id] => 16703131 [patent_doc_number] => 10953044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-23 [patent_title] => Functionalized tissue matrices [patent_app_type] => utility [patent_app_number] => 15/987132 [patent_app_country] => US [patent_app_date] => 2018-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11997 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987132 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/987132
Functionalized tissue matrices May 22, 2018 Issued
Array ( [id] => 15782497 [patent_doc_number] => 10624951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-04-21 [patent_title] => SRPX for treatment of cancer [patent_app_type] => utility [patent_app_number] => 15/985992 [patent_app_country] => US [patent_app_date] => 2018-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 8751 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985992 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/985992
SRPX for treatment of cancer May 21, 2018 Issued
Array ( [id] => 17407343 [patent_doc_number] => 11248214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-15 [patent_title] => Compositions and methods for enhanced gene expression in cone cells [patent_app_type] => utility [patent_app_number] => 15/984085 [patent_app_country] => US [patent_app_date] => 2018-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 28 [patent_no_of_words] => 29166 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15984085 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/984085
Compositions and methods for enhanced gene expression in cone cells May 17, 2018 Issued
Array ( [id] => 16298032 [patent_doc_number] => 20200283755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING [patent_app_type] => utility [patent_app_number] => 16/614549 [patent_app_country] => US [patent_app_date] => 2018-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 100877 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16614549 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/614549
Systems, methods, and compositions for targeted nucleic acid editing May 17, 2018 Issued
Array ( [id] => 13622951 [patent_doc_number] => 20180363027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => STABILIZING COMPOSITIONS AND METHODS FOR EXTRACTION OF RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 15/980682 [patent_app_country] => US [patent_app_date] => 2018-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16643 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15980682 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/980682
Stabilizing compositions and methods for extraction of ribonucleic acid May 14, 2018 Issued
Array ( [id] => 16087103 [patent_doc_number] => 20200197538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => Systemic Delivery of Polypeptides [patent_app_type] => utility [patent_app_number] => 16/612648 [patent_app_country] => US [patent_app_date] => 2018-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17688 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612648 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/612648
Systemic delivery of polypeptides May 13, 2018 Issued
Array ( [id] => 13586459 [patent_doc_number] => 20180344778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => Methods of Enhancing Female Fertility [patent_app_type] => utility [patent_app_number] => 15/976413 [patent_app_country] => US [patent_app_date] => 2018-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15323 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15976413 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/976413
Methods of enhancing female fertility May 9, 2018 Issued
Array ( [id] => 13397593 [patent_doc_number] => 20180250339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-06 [patent_title] => METHODS AND COMPOSITIONS FOR GENE EDITING IN HEMATOPOIETIC STEM CELLS [patent_app_type] => utility [patent_app_number] => 15/970605 [patent_app_country] => US [patent_app_date] => 2018-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20525 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970605 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/970605
Methods and compositions for gene editing in hematopoietic stem cells May 2, 2018 Issued
Array ( [id] => 15899001 [patent_doc_number] => 20200149019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURONATE-2-SULFATASE (IDS) PRODUCED BY HUMAN NEURAL OR GLIAL CELLS [patent_app_type] => utility [patent_app_number] => 16/604427 [patent_app_country] => US [patent_app_date] => 2018-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604427 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604427
Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS) produced by human neural or glial cells Apr 12, 2018 Issued
Array ( [id] => 18620406 [patent_doc_number] => 11753434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-12 [patent_title] => Compositions and methods for transient gene therapy with enhanced stability [patent_app_type] => utility [patent_app_number] => 16/604609 [patent_app_country] => US [patent_app_date] => 2018-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 62 [patent_no_of_words] => 16606 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604609 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604609
Compositions and methods for transient gene therapy with enhanced stability Apr 12, 2018 Issued
Array ( [id] => 13479587 [patent_doc_number] => 20180291336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => METHOD OF MANUFACTURING AND PURIFYING EXOSOMES FROM NON-TERMINALLY DIFFERENTIATED CELLS [patent_app_type] => utility [patent_app_number] => 15/947329 [patent_app_country] => US [patent_app_date] => 2018-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947329 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/947329
METHOD OF MANUFACTURING AND PURIFYING EXOSOMES FROM NON-TERMINALLY DIFFERENTIATED CELLS Apr 5, 2018 Abandoned
Array ( [id] => 13343639 [patent_doc_number] => 20180223359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => CONJUGATED POLYMERIC PARTICLE AND METHOD OF MAKING SAME [patent_app_type] => utility [patent_app_number] => 15/945348 [patent_app_country] => US [patent_app_date] => 2018-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10413 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15945348 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/945348
Conjugated polymeric particle and method of making same Apr 3, 2018 Issued
Menu